ASMB — ASSEMBLY BIOSCIENCES INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ASMB?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their ASMB position last quarter, 2 bought and 1 sold (67% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +2 tracked investors added or increased positions last quarter (Izzy Englander, Ken Griffin)
- +3 tracked investors reported holding ASMB at their latest filing
- −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About ASSEMBLY BIOSCIENCES INC (ASMB)
ASSEMBLY BIOSCIENCES INC (ASMB) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $20M. Across recent filings, tracked investors recorded 4 new positions, 9 increased, 4 reduced, and 2 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ASMB
How many top investors track ASMB
A small number of top investors own this.
ASMB Ownership Composition
How ASSEMBLY BIOSCIENCES INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting ASMB
- Steve CohenSep 30, 2026Point72 Asset ManagementShares362.7KValue$8.5M% Portfolio0.01%
- Izzy EnglanderSep 30, 2026Millennium ManagementShares490.1KValue$11.5M% Portfolio0.00%
- Ken GriffinSep 30, 2026Citadel AdvisorsShares392KValue$9.2M% Portfolio0.00%
Recent activity
- Increased$11.5M(64.03%)Nov 16, 2026
- Reduced$8.5M(-21.25%)Nov 16, 2026
- Increased$9.2M(242.65%)Nov 16, 2026
- Reduced$568.6K(-69.58%)Nov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- Increased$3.3M(354.56%)Feb 17, 2026
- Increased$6.5M(137.88%)May 15, 2026
- Increased$8.2M(27.89%)Aug 14, 2026
- Reduced$192.6K(-0.58%)Nov 14, 2024
- New$117.2KMay 15, 2025
- Increased$647.3K(191.44%)Aug 14, 2025
- Sold$0(-100.00%)Nov 14, 2025
- Increased$3.1M(349.77%)Aug 14, 2026
- New$7.6MNov 14, 2025
- Increased$20.4M(102.90%)Feb 17, 2026
- Reduced$9.5M(-42.71%)May 15, 2026
- Increased$12.7M(33.85%)Aug 14, 2026
- New$175.5KAug 14, 2024
- $1.7MMay 15, 2024
Frequently asked questions
- How many institutional investors hold ASMB?
- 3 tracked institutional investors disclosed a position in ASMB (ASSEMBLY BIOSCIENCES INC) in their most recent 13F filing.
- Who is the largest institutional holder of ASMB?
- Steve Cohen, Point72 Asset Management, holds the largest disclosed position in ASMB, valued at $20M.
- Did institutional ownership of ASMB increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 9 increased, 4 reduced, and 2 fully exited ASMB.
- Where does this ASMB ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.